IBT
XNCR icon

International Biotechnology Trust’s Xencor XNCR Stock Holding History

International Biotechnology Trust’s Portfolio XNCR Stock Details XNCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-18,000
Closed -$395K – 69
2017
Q4 		$395K Hold
18,000
– – 0.14% 64
2017
Q3 		$413K Hold
18,000
– – 0.16% 54
2017
Q2 		$380K Hold
18,000
– – 0.14% 60
2017
Q1 		$430K Sell
18,000
-30,000
-63% -$723K 0.16% 60
2016
Q4 		$1.26M Buy
+48,000
New +$1.15M 0.57% 34

Other funds holding XNCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

International Biotechnology Trust's XNCR Position: Q1 2018 in Review

International Biotechnology Trust sold out of Xencor (XNCR) in Q1 2018, closing a stake of 18,000 shares — an estimated $395K sold.

International Biotechnology Trust first reported a position in XNCR in Q4 2016 and held it in 5 quarters. The position peaked at $1.26M in Q4 2016. 122 funds tracked by Wall St. Rank hold XNCR as of Q1 2018.

  • International Biotechnology Trust reported no remaining Xencor position as of Q1 2018 after selling out during the quarter.
  • International Biotechnology Trust sold 18,000 Xencor shares in Q1 2018, an estimated $395K.
  • International Biotechnology Trust first reported a position in Xencor in Q4 2016 and held it in 5 quarters.
  • International Biotechnology Trust's Xencor position peaked at $1.26M in Q4 2016.
  • 122 funds tracked by Wall St. Rank held Xencor as of Q1 2018.

Based on International Biotechnology Trust's 13F filing for Q1 2018, filed 15 May 2018.